During the past decade, City Clinical Hospital # 13 of Avtozavodsky District of Nizhniy Novgorod conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "City Clinical Hospital # 13 of Avtozavodsky District of Nizhniy Novgorod" are "Type 2 Diabetes Mellitus" (2 trials), "Crohn Disease" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "City Clinical Hospital # 13 of Avtozavodsky District of Nizhniy Novgorod" in a lesser frequency.

Most popular intervention types in "City Clinical Hospital # 13 of Avtozavodsky District of Nizhniy Novgorod" are "Drug" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Diet" (2 trials), "Exercise" (2 trials), "Ranolazine" (2 trials) and "Glimepiride" (1 trials). Other intervention names were less common.

The vast majority of trials in "City Clinical Hospital # 13 of Avtozavodsky District of Nizhniy Novgorod" are 4 trials for "All" genders.

Currently, there are NaN active trials in "City Clinical Hospital # 13 of Avtozavodsky District of Nizhniy Novgorod". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in City Clinical Hospital # 13 of Avtozavodsky District of Nizhniy Novgorod, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in City Clinical Hospital # 13 of Avtozavodsky District of Nizhniy Novgorod, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".